ACCEPT SIMS AI™

AI-enabled screening intelligence and navigation

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
3,962
Screening encounters
4,681
Diagnostic referrals
898
Outstanding pathways
320

Screening pathway

  1. Screening4,681Encounters
  2. Positive finding1,615Documented findings
  3. Referral898Diagnostic referrals
  4. Follow-up1,070Diagnostic visits
  5. Outcome578Resolved pathways

Stage totals use different units. Pending pathways: 320. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 0803 · EXP-0803Synthetic · Site D

Full participant history through 2026-12-12, across modalities and pathways.

  1. · Screening · HPV DNA · Initial · Programme entry
  2. · Screening result · HPV DNA · HPV detected · Adequate
  3. · Triage · VIA · VIA negative
  4. · Surveillance plan · HPV DNA · HPV positive with negative triage · Scheduled for 2027-11-06

Referral-time risk

No matching referral was available at this observation date.

Screened participants

3962 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-1058 · Expanded synthetic participant 1058Site E — Resource-Constrained Navigation Programme
EXP-1059 · Expanded synthetic participant 1059Site B — Peri-Urban Access Programme
EXP-1061 · Expanded synthetic participant 1061Site C — Rural Outreach Programme
EXP-1063 · Expanded synthetic participant 1063Site B — Peri-Urban Access Programme
EXP-1066 · Expanded synthetic participant 1066Site C — Rural Outreach Programme
EXP-1067 · Expanded synthetic participant 1067Site B — Peri-Urban Access Programme
EXP-1068 · Expanded synthetic participant 1068Site A — Urban Referral Hub
EXP-1072 · Expanded synthetic participant 1072Site D — Community Engagement Programme
EXP-1073 · Expanded synthetic participant 1073Site C — Rural Outreach Programme
EXP-1074 · Expanded synthetic participant 1074Site D — Community Engagement Programme
EXP-1075 · Expanded synthetic participant 1075Site D — Community Engagement Programme
EXP-1078 · Expanded synthetic participant 1078Site C — Rural Outreach Programme
EXP-1079 · Expanded synthetic participant 1079Site E — Resource-Constrained Navigation Programme
EXP-1082 · Expanded synthetic participant 1082Site E — Resource-Constrained Navigation Programme
EXP-1083 · Expanded synthetic participant 1083Site D — Community Engagement Programme
EXP-1084 · Expanded synthetic participant 1084Site B — Peri-Urban Access Programme
EXP-1086 · Expanded synthetic participant 1086Site C — Rural Outreach Programme
EXP-1087 · Expanded synthetic participant 1087Site B — Peri-Urban Access Programme
EXP-1088 · Expanded synthetic participant 1088Site C — Rural Outreach Programme
EXP-1089 · Expanded synthetic participant 1089Site D — Community Engagement Programme
EXP-1090 · Expanded synthetic participant 1090Site B — Peri-Urban Access Programme
EXP-1091 · Expanded synthetic participant 1091Site E — Resource-Constrained Navigation Programme
EXP-1093 · Expanded synthetic participant 1093Site A — Urban Referral Hub
EXP-1094 · Expanded synthetic participant 1094Site C — Rural Outreach Programme
EXP-1095 · Expanded synthetic participant 1095Site C — Rural Outreach Programme

Programme insights

Encounters by modality

VIA
1784
HPV DNA
2235
Cytology
662

Navigation activity

Barrier documented
798
Contact attempt
1313
Navigation intervention
341
Diagnostic booking
1119
Diagnostic visit
1070

Documented barriers

Contact difficulty
256
Transport difficulty
262
Appointment coordination
280

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.